| Involvement of mitochondrial and B-RAF/ERK signaling pathways in berberine-induced apoptosis in human melanoma cells. | |
| | |
MedLine Citation:
|
PMID: 21527846 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The natural isoquinoline alkaloid berberine exhibits a wide spectrum of biological activities including antitumor activity, but its mechanism of action remains to be fully elucidated. Here, we report that berberine induced apoptosis in human melanoma cells, through a process that involved mitochondria and caspase activation. Berberine-induced activation of a number of caspases, including caspases 3, 4, 7, 8, and 9. Pan-caspase inhibitor, z-VAD-fmk, and caspase-8 and caspase-9 inhibitors prevented apoptosis. Berberine also led to the generation of the p20 cleavage fragment of BAP31, involved in directing proapoptotic signals between the endoplasmic reticulum and the mitochondria. Treatment of SK-MEL-2 melanoma cells with berberine induced disruption of the mitochondrial transmembrane potential, release of cytochrome c and apoptosis-inducing factor from the mitochondria to the cytosol, generation of reactive oxygen species (ROS), and a decreased ATP/ADP ratio. Overexpression of bcl-xL by gene transfer prevented berberine-induced cell death, mitochondrial transmembrane potential loss, and cytochrome c and apoptosis-inducing factor release, but not ROS generation. N-acetyl-L-cysteine inhibited the production of ROS, but did not abrogate the berberine-induced apoptosis. Inhibition of extracellular signal-regulated kinase (ERK) phosphorylation, by using the mitogen-activated protein kinase/ERK kinase inhibitor PD98059, and reduction of B-RAF levels by silencing RNA induced cell death of SK-MEL-2 cells, and diminished the berberine concentration required to promote apoptosis. These data show that berberine-induced apoptosis in melanoma cells involves mitochondria and caspase activation, but ROS generation was not essential. Our results indicate that inhibition of B-RAF/ERK survival signaling facilitates the cell death response triggered by berberine. |
| | |
Authors:
|
Ana Burgeiro; Consuelo Gajate; El Habib Dakir; Janny A Villa-Pulgarín; Paulo J Oliveira; Faustino Mollinedo |
Related Documents
:
|
10706096 - The glucocorticoid receptor mediates a survival signal in human mammary epithelial cells. 19724926 - In vitro anti-inflammatory and anticancer activities of extracts of acalypha alopecuroi... 21481006 - Areca nut extracts enhance the development of cd11b(+) gr-1(+) cells with the character... 21204666 - T lymphocytes apoptosis and mitochondrial membrane potential in down's syndrome. 20358356 - Adipose tissue lymphocytes: types and roles. 18424756 - Il-27 activates human monocytes via stat1 and suppresses il-10 production but the infla... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Anti-cancer drugs Volume: 22 ISSN: 1473-5741 ISO Abbreviation: Anticancer Drugs Publication Date: 2011 Jul |
Date Detail:
|
Created Date: 2011-06-01 Completed Date: 2011-08-23 Revised Date: 2011-09-08 |
Medline Journal Info:
|
Nlm Unique ID: 9100823 Medline TA: Anticancer Drugs Country: England |
Other Details:
|
Languages: eng Pagination: 507-18 Citation Subset: IM |
Affiliation:
|
Instituto de Biología Molecular y Celular del Cáncer, Centro de Investigación del Cáncer, Consejo Superior de Investigaciones Científicas - Universidad de Salamanca, Spain. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adenine Nucleotides
/
metabolism Antineoplastic Agents, Phytogenic / pharmacology* Apoptosis / drug effects* Berberine / pharmacology* Blotting, Western Caspases / metabolism Cell Cycle / drug effects Cell Line, Tumor Chromatography, High Pressure Liquid Cytochromes c / metabolism Down-Regulation / drug effects Extracellular Signal-Regulated MAP Kinases / physiology* Flow Cytometry G1 Phase / drug effects G2 Phase / drug effects Humans Melanoma / physiopathology* Microscopy, Confocal Mitochondria / drug effects* Proto-Oncogene Proteins B-raf / biosynthesis, physiology* RNA, Small Interfering / pharmacology Reactive Oxygen Species / metabolism Signal Transduction / drug effects* |
| Chemical | |
Reg. No./Substance:
|
0/Adenine Nucleotides; 0/Antineoplastic Agents, Phytogenic; 0/RNA, Small Interfering; 0/Reactive Oxygen Species; 2086-83-1/Berberine; 9007-43-6/Cytochromes c; EC 2.7.1.37/BRAF protein, human; EC 2.7.11.1/Proto-Oncogene Proteins B-raf; EC 2.7.11.24/Extracellular Signal-Regulated MAP Kinases; EC 3.4.22.-/Caspases |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Microvascular Invasion is a Better Predictor of Tumor Recurrence and Overall Survival After Surgical...
Next Document: Telecare is a valuable tool for hypertension management, a systematic review and meta-analysis.